3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Venous Thromboembolism
1
TP53 Y220C Mutation
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pulmonary Embolism
1
Prostatic Neoplasms, Castration-Resistant
1
Peripheral Nervous System Diseases
1
Neoplasms
1
Liver Cirrhosis
1
Leiomyosarcoma
1
Healthy Participants
1
Healthy Adult Participants
1
Endometrial Neoplasms
1
Drug-drug Interaction,SHR3680
1
Cardiotoxicity
1
Breast Neoplasms
1
Advanced Solid Malignancies
1
Interventions
Injections
13
pembrolizumab
10
tislelizumab
9
toripalimab
6
atezolizumab
4
Nivolumab
4
Carboplatin
3
trastuzumab deruxtecan
2
olaparib
2
lenvatinib
2
Pemetrexed
2
Paclitaxel
2
Oxaliplatin
2
Gemcitabine
2
Fluorouracil
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Bevacizumab
2
zimberelimab
1
talazoparib
1
spartalizumab
1
sotorasib
1
serabelisib
1
penpulimab
1
niraparib
1
nedaplatin
1
mirdametinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
Rosuvastatin Calcium
×
1 year
×
Clear all
No trials found.